Search research articles
Contact Us
Filters
Showing results (81-90 of 240) with videos related to
Page
of 24
Sort By:
American Journal of Clinical Oncology
|
June 1, 1996
Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neck
M E Bensmaine, N Azli, C Domenge, et al.
Bulletin Du Cancer
|
September 25, 2001
[Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer]
M Ducreux, K Fizazi, J F Seitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase II study of oral miltefosine in patients with squamous cell head and neck cancer
J Verweij, D Gandia, A S Planting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2006
Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy
J Guigay, S Temam, J Bourhis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites
J Bernadou, B Monsarrat, H Roche, et al.
Clinical Chemistry
|
June 1, 1985
Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonance
J Bernadou, J P Armand, A Lopez, et al.
Therapie
|
July 1, 1994
[Pharmacokinetics of low-dose lithium in healthy volunteers]
P Allain, A Le Bouil, A Turcant, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
May 13, 1982
[Malignant systemic mastocytosis (author's transl)]
P Armand, J Gardais, C Simard, et al.
Investigational New Drugs
|
January 1, 1987
Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometry
M C Malet-Martino, P Servin, J Bernadou, et al.
Annales De Dermatologie Et De Venereologie
|
January 1, 1993
[Complete remission of cutaneous squamous cell carcinoma treated with interferon alpha and 2a-isotretinoin after failure of usual treatments]
T Nguyen, M De Forni, J P Armand, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 240) with videos related to
Sort By:
Page
of 24
American Journal of Clinical Oncology
|
June 1, 1996
Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neck
M E Bensmaine, N Azli, C Domenge, et al.
Bulletin Du Cancer
|
September 25, 2001
[Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer]
M Ducreux, K Fizazi, J F Seitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase II study of oral miltefosine in patients with squamous cell head and neck cancer
J Verweij, D Gandia, A S Planting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2006
Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy
J Guigay, S Temam, J Bourhis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites
J Bernadou, B Monsarrat, H Roche, et al.
Clinical Chemistry
|
June 1, 1985
Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonance
J Bernadou, J P Armand, A Lopez, et al.
Therapie
|
July 1, 1994
[Pharmacokinetics of low-dose lithium in healthy volunteers]
P Allain, A Le Bouil, A Turcant, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
May 13, 1982
[Malignant systemic mastocytosis (author's transl)]
P Armand, J Gardais, C Simard, et al.
Investigational New Drugs
|
January 1, 1987
Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometry
M C Malet-Martino, P Servin, J Bernadou, et al.
Annales De Dermatologie Et De Venereologie
|
January 1, 1993
[Complete remission of cutaneous squamous cell carcinoma treated with interferon alpha and 2a-isotretinoin after failure of usual treatments]
T Nguyen, M De Forni, J P Armand, et al.
Page
of 24